Explore ViiV Healthcare
ViiV Healthcare ranks #1 company in the PatientView
ViiV Healthcare ranks #1 company in the PatientView ‘Corporate Reputation of Pharma – from the Patient Perspective 2019 – 2020’ survey
The HIV community is at the heart of everything we do at ViiV Healthcare and we are incredibly proud to have been recognised by PatientView’s ‘Corporate Reputation of Pharma – from the Patient Perspective 2019 – 2020’ [please hyperlink "PatientView’s ‘Corporate Reputation of Pharma – from the Patient Perspective 2019 – 2020’" with this link - http://www.patient-view.com/bull-about-corporate-reputation-of-pharma-2019-2020.html ] report as #1 for the seventh consecutive year, achieving top scores across all 12 survey indicators.
Every day, we work hard to design and implement community programmes and clinical trials that focus on breaking down HIV stigma, improving health-related quality of life and supporting people affected by HIV to ensure access to the medicines they need, making progress towards ending the AIDS epidemic by the UNAIDS target of 2030.
The results of the PatientView report will provide valuable insights that will help us continue to drive breakthroughs towards our ultimate ambition to end AIDS.
To all the individuals and organisations who took the time to participate in the survey and recognise our work and role in the HIV community, we thank you. Your partnership motivates us to continue our work with focus and purpose so that no person living with HIV is left behind.
Mike Graham, Country Manager Australia and Fraser Drummond, Country Medical Director ANZ